药物联合改良式森田疗法及内观疗法治疗慢性精神分裂症的临床疗效

The clinical effect of modified Morita therapy combined with Nai Kan therapy on chronic schizophrenia patients

目的探讨改良式森田疗法联合内观疗法对慢性精神分裂症患者的临床疗效。方法选取我院2016年4月至12月的80例慢性精神分裂症患者,随机分为森田内观整合组和森田组,每组各40例。两组均进行系统的抗精神病药物治疗、常规护理及改良式森田治疗,但森田内观整合组在此基础上进行内观疗法。于治疗前及治疗后第3月、第6月分别以阳性与阴性症状量表(PANSS)、住院精神病人社会功能评定量表(SSPI)、自知力及治疗态度问卷(ATIQ)量表对两组患者疗效进行评定。结果两组患者在治疗前PANSS,SSPI和ATIQ评分,组间无明显差异(P>0.05)。在治疗的3月后、6月后,森田内观整合组的PANSS评分评分低于森田组,ATIQ和SSPI评分高于森田组,且上述差异均有统计学意义(P<0.05)。结论对慢性精神分裂症患者进行改良式森田疗法联合内观疗法治疗可以更好的改善患者的认知能力、社会功能及症状,提高患者的生活质量。

Objective To study the clinical effect of chronic schizophrenia patients. Methods From April 2016 modified Morita therapy combined with Naikan therapy on to December 2016, 80 cases of chronic schizophrenia pa- tients of our hospital were collected and randomly divided into Morita group （ n = 40 cases ） and integrated Morita group （ n=40 cases ） . Both groups continued on the systematic antipsychotics and nursing care as well as modified Morita therapy, meanwhile the integrated Morita group were given Naikan therapy. Then the negative symptoms Scale （ PANSS ）, the length of the mental patient social function rating Scale （ SSPI ） and self-knowledge and treatment attitude question- naire （ ATIQ ） Scale were evaluated and compared between the two groups before and 3 months, 6 months separately after the treatment. Results There was no significant differences of scores of PANSS, SSPI and ATIQ between the two groups before therapy （P〉0.05） .3 months and 6 months after treatment, , scores of PANSS of integrated Morita group were lower than that of Morita group, meanwhile scores of ATIQ and SSPI of integrated Morita group were higher than that of Morita group, andall the differences above were statistically significant （P 〈 0.05 ） . Conclusion Modified Morita therapy combined with Naikan therapy can be better to improve the patient＇s cognitive function, social function and symptoms as well as the quality of life of patients with chronic schizophrenia.